Company intelligence / Profile preview

MERSCOPE Ultra

Waltham, Massachusetts, United States

Ownership: Private
Employees: ~158

Overview

Vizgen is a privately held spatial biology and multiomics company that develops advanced tools for in situ single-cell spatial genomics. The company's flagship product, the MERSCOPE Ultra Platform, is powered by MERFISH 2.0 chemistry and enables high-throughput, high-resolution mapping of up to 1,000 custom genes across large tissue sections. Following its merger with Ultivue in October 2024, Vizgen has expanded its capabilities to offer unified spatial multiomics solutions, combining spatial transcriptomics with multiplex proteomic profiling. Headquartered in Waltham, Massachusetts, Vizgen serves academic, clinical, and biopharmaceutical researchers globally to accelerate drug discovery and translational medicine.

Modalities: Device
Industry: Molecular Diagnostics

Partnerships

HamamatsuKeyGene

Beyond the preview

Go deeper on MERSCOPE Ultra.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MERSCOPE Ultra.

Explore the full profile